Transgenomic has appointed Stephen Miller senior vice president and general manager of its patient testing business unit.
Miller most recently provided commercial and strategic consultancy services to a variety of diagnostic companies, including Transgenomic. Prior to that, he was chief commercial officer at BG Medicine. Miller has also served as president and chief commercial officer for Mira Dx, and vice president of sales and marketing for Athena Diagnostics.
Dirk Evers is now VP of data operations at Molecular Health in Heidelberg, Germany. Previously, he was senior vice president of informatics at the New York Genome Center and was also the director of computational biology at Illumina. He holds a PhD in bioinformatics from Bielefeld University.
Tute Genomics, which provides a cloud-based clinical genome interpretation pipeline, has appointed Mingfu Zhu as director of bioinformatics. Zhu was previously an assistant professor at the Center for Human Genome Variation at Duke University Medical Center. He holds a PhD in mathematics from Clemson University and a BS in mathematics from the University of Science and Technology of China.
NuVasive, a medical device company that develops spinal surgical products and procedures, has appointed Greg Lucier to its board of directors. Lucier is the chairman and CEO of Life Technologies. He has also held senior management positions at General Electric. He holds a BS in industrial engineering from Pennsylvania State University and an MBA from Harvard Graduate School of Business Administration.